Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06283745
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-02-21
Brief Title:
Randomized Clinical Trial of Intranasal Injection of Platelet-Rich Plasma for Treatment of Parosmia
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Randomized Clinical Trial of Intranasal Injection of Platelet-Rich Plasma for Treatment of Parosmia
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This randomized clinical trial will evaluate the benefit of platelet-rich plasma PRP in the treatment of qualitative olfactory dysfunction parosmia PRP can be isolated from a patients own blood and has been found in previous studies to have anti-inflammatory and pro-regenerative properties It has been used across multiple specialties such as Orthopedics Facial Plastics Dermatology Neurology in injected form to treat a wide variety of tissues to encourage the bodys inherent regenerative capacity The investigators have completed a randomized controlled trial here ending in 2022 evaluating its use in post-SARS-CoV-2 olfactory loss which demonstrated safety and efficacy Therefore the investigators aim to assess the ability of PRP to improve olfactory function in patients with parosmia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None